EP20 COMPARATIVE EFFICACY OF VONOPRAZAN WITH PROTON PUMP INHIBITORS AND OTHER POTASSIUM-COMPETITIVE ACID BLOCKERS FOR REFLUX ESOPHAGITIS: A NETWORK ...

166 EXTERNAL VALIDATION DEMONSTRATES HIGH PREDICTIVE VALUE OF THE LYON SCORE: A NOVEL REFLUX SCORING SYSTEM BASED ON THE LYON CONSENSUS 2.0

165 MANOMETRIC SCREENING USING THE NOVEL MILAN SCORE IDENTIFIES LIKELIHOOD OF OBJECTIVE GASTROESOPHAGEAL REFLUX IN PATIENTS WITH LARYNGOPHARYNGEAL REFLUX ...

Mo1264 IDENTIFYING INDEPENDENT RISK FACTORS FOR PHARYNGEAL ACID REFLUX EPISODES IN PATIENTS WITH EXTRAESOPHAGEAL SYMPTOMS AND PATHOLOGIC ESOPHAGOPHARYNGEAL ...

95 VALIDATION OF RISK ASSESSMENT TOOLS FOR THE DETECTION OF BARRETT'S ESOPHAGUS IN PATIENTS WITHOUT CHRONIC REFLUX SYMPTOMS

93 IN BARRETT'S ESOPHAGUS, REFLUX INDUCES FEATURES OF EPITHELIAL-MESENCHYMAL PLASTICITY MEDIATED BY APE/REF-1 REDOX FUNCTION: EVIDENCE FROM STUDIES IN ...

Tu1250 ANTI-REFLUX MECHANISM OF DIAPHRAGMATIC BREATHING IN PATIENTS WITH REFLUX SYMPTOMS

1291 CHRONIC GASTROESOPHAGEAL REFLUX PROMOTES CHEMORESISTANCE IN ESOPHAGEAL ADENOCARCINOMA THROUGH APE1-REDOX-DEPENDENT PRDX2 ACTIVATION AND FERROPTOSIS ...

Mo1310 FINAL SAFETY AND EFFECTIVENESS RESULTS OF VONOPRAZAN IN CHINESE REFLUX ESOPHAGITIS PATIENTS: A MULTI-CENTER PROSPECTIVE REAL-WORLD STUDY

21 INCREASED REFLUX SECONDARY BILE ACIDS ARE ASSOCIATED WITH SHIFTS TO THE MICROBIOME AND TRANSCRIPTOME IN BARRETT'S ESOPHAGUS